Drugs like Ozempic, Wegovy, and Saxenda have become hugely popular. But could they cause psychological side effects in their ...

India's obesity crisis is intensifying, with big pharma companies like Eli Lilly and Novo Nordisk competing to introduce ...

Vivani Medical completed enrollment in its LIBERATE-1 trial, testing a six-month GLP-1 implant for weight management. Top-line results are expected by mid-2025.

The phase 3b STEP UP trial in more than 1,400 patients compared a 7.2mg weekly subcutaneous injection of semaglutide to the standard 2.6mg weekly dose sold as Wegovy or a matched placebo.

In March 2023, more underwhelming data from a 320 patient Phase 2 study, which showed "people receiving pemvidutide achieved average weight losses of 7.3%, 9.4% and 10.7% at the 1.2 mg ...

It’s also slashing the cost of 2 mg and 5 mg vials by $50 a month ... sold under the brand names Ozempic and Wegovy. Compounding pharmacies have 60 or 90 days left to offer off-brand versions.

Or your doctor might recommend the maximum dosage of 2 mg once per week ... is also the active drug in the medication Wegovy. And Wegovy is approved for weight management. The dosage of Wegovy ...

Ozempic came out with a higher-strength, 2 mg dose that was not approved until ... Novo Nordisk went ahead and branded their weight-loss product as Wegovy. It’s still Ozempic, but it’s branded ...